Literature DB >> 10220862

Merosin-deficient congenital muscular dystrophy: the spectrum of brain involvement on magnetic resonance imaging.

J Philpot1, F Cowan, J Pennock, C Sewry, V Dubowitz, G Bydder, F Muntoni.   

Abstract

Children with merosin-deficient congenital muscular dystrophy (CMD) have striking white matter changes on T-2 weighted brain magnetic resonance imaging (MRI). There have been occasional cases with structural abnormalities, mainly involving the occipital cortex. We report our brain imaging findings in 14 children with merosin-deficient CMD. Ten cases had a severe reduction or absence of merosin on immunocytochemistry and four cases had partial reduction. All 14 cases had white matter changes, which appeared after the first 6 months of life and persisted with time. The changes were diffuse and the oldest child scanned (14 years) also showed involvement of the U fibres. Five children with total absence of merosin also had structural abnormalities. One child had moderate mental retardation and epilepsy, mainly characterised by complex partial seizures, with atypical absences, which had been difficult to treat. Brain MRI showed marked occipital agyria and pontocerebellar hypoplasia. The gyral pattern of the rest of the brain looked normal. The four other cases, all with normal intelligence, also had cerebellar hypoplasia with variable involvement of the pons. They did not, however, have neuronal migration defects. It is recognised that several forms of congenital muscular dystrophy, namely Fukuyama CMD, muscle-eye-brain disease and Walker-Warburg syndrome, have structural brain abnormalities and associated severe mental retardation. Our cases demonstrate that a range of structural malformations can also be found in a significant number of children with merosin-deficient CMD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10220862     DOI: 10.1016/s0960-8966(98)00110-2

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  17 in total

1.  Child with Isolated Motor Delay: Look at the Neuroimage.

Authors:  Indar Kumar Sharawat; Ananthanarayanan Kasinathan; Naveen Sankhyan
Journal:  Indian J Pediatr       Date:  2018-05-22       Impact factor: 1.967

2.  Laminin regulates postnatal oligodendrocyte production by promoting oligodendrocyte progenitor survival in the subventricular zone.

Authors:  Jenne Relucio; Michael J Menezes; Yuko Miyagoe-Suzuki; Shin'ichi Takeda; Holly Colognato
Journal:  Glia       Date:  2012-06-17       Impact factor: 7.452

3.  Transgenic overexpression of the α7 integrin reduces muscle pathology and improves viability in the dy(W) mouse model of merosin-deficient congenital muscular dystrophy type 1A.

Authors:  Jinger A Doe; Ryan D Wuebbles; Erika T Allred; Jachinta E Rooney; Margaret Elorza; Dean J Burkin
Journal:  J Cell Sci       Date:  2011-06-07       Impact factor: 5.285

4.  Laminin-111 improves muscle repair in a mouse model of merosin-deficient congenital muscular dystrophy.

Authors:  Pam M Van Ry; Priscilla Minogue; Bradley L Hodges; Dean J Burkin
Journal:  Hum Mol Genet       Date:  2013-09-05       Impact factor: 6.150

5.  Spectrum of pontocerebellar hypoplasia in 13 girls and boys with CASK mutations: confirmation of a recognizable phenotype and first description of a male mosaic patient.

Authors:  Lydie Burglen; Sandra Chantot-Bastaraud; Catherine Garel; Mathieu Milh; Renaud Touraine; Ginevra Zanni; Florence Petit; Alexandra Afenjar; Cyril Goizet; Sabina Barresi; Aurélie Coussement; Christine Ioos; Leila Lazaro; Sylvie Joriot; Isabelle Desguerre; Didier Lacombe; Vincent des Portes; Enrico Bertini; Jean-Pierre Siffroi; Thierry Billette de Villemeur; Diana Rodriguez
Journal:  Orphanet J Rare Dis       Date:  2012-03-27       Impact factor: 4.123

Review 6.  The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review.

Authors:  K J Jones; G Morgan; H Johnston; V Tobias; R A Ouvrier; I Wilkinson; K N North
Journal:  J Med Genet       Date:  2001-10       Impact factor: 6.318

7.  Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy.

Authors:  Jachinta E Rooney; Jolie R Knapp; Bradley L Hodges; Ryan D Wuebbles; Dean J Burkin
Journal:  Am J Pathol       Date:  2012-02-06       Impact factor: 4.307

8.  Merosin-deficient congenital muscular dystrophy (CMD): a study of 25 Brazilian patients using MRI.

Authors:  Claudia C Leite; Leandro T Lucato; Maria G M Martin; Lucio G Ferreira; Maria B D Resende; Mary S Carvalho; Suely K N Marie; J Randy Jinkins; Umbertina C Reed
Journal:  Pediatr Radiol       Date:  2005-03-05

9.  New FKRP mutations causing congenital muscular dystrophy associated with mental retardation and central nervous system abnormalities. Identification of a founder mutation in Tunisian families.

Authors:  Nacim Louhichi; Chahnez Triki; Susana Quijano-Roy; Pascale Richard; Samira Makri; Mériem Méziou; Brigitte Estournet; Slah Mrad; Norma B Romero; Hammadi Ayadi; Pascale Guicheney; Faiza Fakhfakh
Journal:  Neurogenetics       Date:  2003-12-02       Impact factor: 2.660

10.  beta1 integrin maintains integrity of the embryonic neocortical stem cell niche.

Authors:  Karine Loulier; Justin D Lathia; Veronique Marthiens; Jenne Relucio; Mohamed R Mughal; Sung-Chun Tang; Turhan Coksaygan; Peter E Hall; Srinivasulu Chigurupati; Bruce Patton; Holly Colognato; Mahendra S Rao; Mark P Mattson; Tarik F Haydar; Charles Ffrench-Constant
Journal:  PLoS Biol       Date:  2009-08-18       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.